Fall School Closure = Long-Term Health, Learning Costs for Kids
“At what point do our public health interventions themselves cause a public health crisis?” biostatistics professor Christina Ramirez writes in RealClearPolitics.
“Failure to reopen schools in the fall will inflict greater hardship and potentially life-long developmental deficits on our most vulnerable children and grandchildren long after this pandemic has faded–a tragically ironic victimization of those least at risk of morbidity and mortality. If kids are indeed our future, we must find a way to reopen the schools.”
🎬 WATCH LIVE at 3 p.m. ET: President Trump participates in Kids First—Getting America’s Children Safely Back to School
“President Donald Trump on Tuesday announced the U.S. government will purchase 100 million doses of Moderna’s experimental coronavirus vaccine, which is currently in late-stage human trials,” Noah Higgins-Dunn reports. “We are investing in the development and manufacture of the top six vaccine candidates to ensure rapid delivery. The military is ready to go, they’re ready to deliver a vaccine to Americans as soon as one is fully approved by the FDA,” President Trump said. Read more in CNBC.
“On Monday Carmen Best shocked Seattle by resigning as police chief. It was her last act of public service, coming hours after the City Council voted 7-1 to cut money and jobs from its police force—which members make clear is only a first step in dismantling local law enforcement . . . In the name of Black Lives Matter the progressives in Seattle have now pushed out a black police chief,” The Wall Street Journal editorial board writes.
This week, “ten U.S. Government agencies and departments presented detailed plans on how they would leverage their unique capabilities to remove legal and regulatory barriers to women’s full and free participation in the global economy. These plans build upon progress already made under the Women’s Global Development and Prosperity (W-GDP) Initiative,” Ivanka Trump and National Security Adviser Robert O’Brien write for CNBC.